Literature DB >> 3966951

Reduction of infarct size. An attractive concept: useful--or possible--in humans?

W Kübler, A Doorey.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3966951      PMCID: PMC481713          DOI: 10.1136/hrt.53.1.5

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  30 in total

1.  Myocardial protection.

Authors:  H J Bretschneider
Journal:  Thorac Cardiovasc Surg       Date:  1980-10       Impact factor: 1.827

2.  A randomized trial of intracoronary streptokinase in the treatment of acute myocardial infarction.

Authors:  J L Anderson; H W Marshall; B E Bray; J R Lutz; P R Frederick; F G Yanowitz; F L Datz; S C Klausner; A D Hagan
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

3.  Thrombolysis in acute evolving myocardial infarction. A new potential for myocardial salvage.

Authors:  H J Swan
Journal:  N Engl J Med       Date:  1983-06-02       Impact factor: 91.245

4.  Selective intracoronary thrombolysis in acute myocardial infarction and unstable angina pectoris.

Authors:  P Rentrop; H Blanke; K R Karsch; H Kaiser; H Köstering; K Leitz
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

5.  Reduction of CK and CK-MB indexes of infarct size by intravenous nitroglycerin.

Authors:  W D Bussmann; D Passek; W Seidel; M Kaltenbach
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

6.  Effects of graded hypoxia on contraction of cultured chick embryo ventricular cells.

Authors:  W H Barry; J Pober; J D Marsh; S R Frankel; T W Smith
Journal:  Am J Physiol       Date:  1980-11

7.  Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase.

Authors:  K P Rentrop; H Blanke; K R Karsch; V Wiegand; H Köstering; H Oster; K Leitz
Journal:  Clin Cardiol       Date:  1979-10       Impact factor: 2.882

8.  Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

Authors:  A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

9.  Effect of myocardial oxygen consumption on infarct size in experimental coronary artery occlusion.

Authors:  K D Müller; S Sass; M G Gottwik; W Schaper
Journal:  Basic Res Cardiol       Date:  1982 Mar-Apr       Impact factor: 17.165

10.  Intracoronary thrombolysis in acute myocardial infarction: duration of ischemia as a major determinant of late results after recanalization.

Authors:  F Schwarz; G Schuler; H Katus; M Hofmann; J Manthey; H Tillmanns; H C Mehmel; W Kübler
Journal:  Am J Cardiol       Date:  1982-11       Impact factor: 2.778

View more
  4 in total

Review 1.  Cardiogenic shock.

Authors:  C E Handler
Journal:  Postgrad Med J       Date:  1985-08       Impact factor: 2.401

2.  Pathological changes after intravenous streptokinase treatment in eight patients with acute myocardial infarction.

Authors:  S G Richardson; D C Allen; P Morton; J G Murtagh; M E Scott; D B O'Keeffe
Journal:  Br Heart J       Date:  1989-05

3.  In vivo production of prostacyclin and thromboxane in patients with acute myocardial infarction.

Authors:  P Henriksson; A Wennmalm; O Edhag; O Vesterqvist; K Green
Journal:  Br Heart J       Date:  1986-06

Review 4.  What is established in thrombolytic therapy of acute myocardial infarction? Pharmacological approaches.

Authors:  W Kübler; C Bode; A Schömig; G Schuler; F Schwarz
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.